M-A | Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes.

Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis – The Lancet Diabetes & Endocrinology

Commentaries:

No justification for bespoke antihypertensive intervention in type 2 diabetes – medwire News

Blood pressure control according to type 2 diabetes status – The Lancet Diabetes & Endocrinology (free registration required)

Commentary on Twitter

Online—Blood pressure-lowering treatment for prevention of major #cardiovascular diseases in people with and without type 2 #diabetes: an individual participant-level data meta-analysis https://t.co/AmNxyW9Via #T2D #BloodPressure #hypertension #openaccess pic.twitter.com/NfdLktZXai

— The Lancet Diabetes & Endocrinology (@TheLancetEndo) July 25, 2022